{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:23:38Z","timestamp":1790969018688,"version":"4.1.0"},"reference-count":22,"publisher":"American Society of Hematology","issue":"1","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,14]]},"DOI":"10.1182\/bloodadvances.2024013792","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T21:13:36Z","timestamp":1729890816000},"page":"162-165","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7868-7469","authenticated-orcid":false,"given":"Francesco","family":"Autore","sequence":"first","affiliation":[{"name":"1Dipartimento di Scienze di Laboratorio ed Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Visentin","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Hematology Unit, Universit\u00e0 degli Studi di Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Deodato","sequence":"additional","affiliation":[{"name":"3Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2592-8724","authenticated-orcid":false,"given":"Candida","family":"Vitale","sequence":"additional","affiliation":[{"name":"4Division of Hematology, A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Galli","sequence":"additional","affiliation":[{"name":"1Dipartimento di Scienze di Laboratorio ed Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8084-9009","authenticated-orcid":false,"given":"Alberto","family":"Fresa","sequence":"additional","affiliation":[{"name":"1Dipartimento di Scienze di Laboratorio ed Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Fazzi","sequence":"additional","affiliation":[{"name":"5U.O. Ematologia, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sanna","sequence":"additional","affiliation":[{"name":"6Hematology Unit, Department of Oncology, Azienda Ospedaliera Universitaria di Careggi, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Olivieri","sequence":"additional","affiliation":[{"name":"7Clinica Ematologia di Udine, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Scortechini","sequence":"additional","affiliation":[{"name":"8Clinica di Ematologia, Azienda ospedaliero Universitaria delle Marche, Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ilaria","family":"Del Principe","sequence":"additional","affiliation":[{"name":"9Dipartimento di Biomedicina e Prevenzione, Universit\u00e0 degli studi di Roma Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Sportoletti","sequence":"additional","affiliation":[{"name":"10Department of Medicine and Surgery, Institute of Hematology and Center for Hemato-Oncology Research (CREO), University of Perugia, A.O. Santa Maria della Misericordia di Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idanna","family":"Innocenti","sequence":"additional","affiliation":[{"name":"1Dipartimento di Scienze di Laboratorio ed Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2123-7675","authenticated-orcid":false,"given":"Marta","family":"Coscia","sequence":"additional","affiliation":[{"name":"4Division of Hematology, A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Tedeschi","sequence":"additional","affiliation":[{"name":"3Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1222-6149","authenticated-orcid":false,"given":"Livio","family":"Trentin","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Hematology Unit, Universit\u00e0 degli Studi di Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Candoni","sequence":"additional","affiliation":[{"name":"11Section of Haematology, Dept. of Medical and Surgical Sciences, Universit\u00e0 degli Studi di Modena e Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Busca","sequence":"additional","affiliation":[{"name":"4Division of Hematology, A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8287-928X","authenticated-orcid":false,"given":"Livio","family":"Pagano","sequence":"additional","affiliation":[{"name":"1Dipartimento di Scienze di Laboratorio ed Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy"},{"name":"12Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica, ed Ematologia, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8327-1396","authenticated-orcid":false,"given":"Luca","family":"Laurenti","sequence":"additional","affiliation":[{"name":"1Dipartimento di Scienze di Laboratorio ed Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy"},{"name":"12Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica, ed Ematologia, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"issue":"8","key":"2025011315513021500_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A\u00a0novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"2025011315513021500_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/17474086.2018.1407645","article-title":"A\u00a0review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia","volume":"11","author":"Tadmor","year":"2018","journal-title":"Expert Rev Hematol"},{"issue":"5","key":"2025011315513021500_bib3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000514071","article-title":"Immune dysfunction in patients with chronic lymphocytic leukemia and challenges during COVID-19 pandemic","volume":"144","author":"Langerbeins","year":"2021","journal-title":"Acta Haematol"},{"issue":"25","key":"2025011315513021500_bib4","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1182\/blood.2020008824","article-title":"Outcomes of patients with\u00a0hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients","volume":"136","author":"Vijenthira","year":"2020","journal-title":"Blood"},{"issue":"12","key":"2025011315513021500_bib5","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/ajh.27093","article-title":"The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: a study by ERIC, the European Research Initiative on CLL","volume":"98","author":"Visentin","year":"2023","journal-title":"Am J Hematol"},{"issue":"9","key":"2025011315513021500_bib6","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1038\/s41375-020-0959-x","article-title":"COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus","volume":"34","author":"Scarf\u00f2","year":"2020","journal-title":"Leukemia"},{"issue":"18","key":"2025011315513021500_bib7","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1182\/blood.2021011841","article-title":"COVID-19 in patients with CLL: improved survival outcomes and update on management strategies","volume":"138","author":"Roeker","year":"2021","journal-title":"Blood"},{"issue":"10","key":"2025011315513021500_bib8","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1182\/blood.2020006965","article-title":"Outcomes of COVID-19 in patients with CLL: a multicenter international experience","volume":"136","author":"Mato","year":"2020","journal-title":"Blood"},{"issue":"3","key":"2025011315513021500_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/cancers14030558","article-title":"Outcome of SARS-CoV-2-infected polish patients with chronic lymphocytic leukemia","volume":"14","author":"Pu\u0142a","year":"2022","journal-title":"Cancers"},{"issue":"12","key":"2025011315513021500_bib10","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41409-023-02093-2","article-title":"Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab\/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic","volume":"58","author":"Galli","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"26","key":"2025011315513021500_bib11","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood.2022017257","article-title":"Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey","volume":"140","author":"Pagano","year":"2022","journal-title":"Blood"},{"issue":"9","key":"2025011315513021500_bib12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s40265-022-01731-1","article-title":"Tixagevimab\u00a0+ cilgavimab: first approval","volume":"82","author":"Keam","year":"2022","journal-title":"Drugs"},{"issue":"23","key":"2025011315513021500_bib13","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood.2021011568","article-title":"Efficacy of the BNT162b2 MRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia","volume":"137","author":"Herishanu","year":"2021","journal-title":"Blood"},{"issue":"9","key":"2025011315513021500_bib14","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1038\/s41375-021-01270-w","article-title":"COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia","volume":"35","author":"Roeker","year":"2021","journal-title":"Leukemia"},{"issue":"7","key":"2025011315513021500_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41408-021-00528-x","article-title":"Antibody responses after first and second covid-19 vaccination in patients with chronic lymphocytic leukaemia","volume":"11","author":"Parry","year":"2021","journal-title":"Blood Cancer J"},{"issue":"1","key":"2025011315513021500_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/bloodadvances.2021006215","article-title":"Humoral response to MRNA anti-COVID-19 vaccines BNT162b2 and MRNA-1273 in patients with chronic lymphocytic leukemia","volume":"6","author":"Bagacean","year":"2022","journal-title":"Blood Adv"},{"issue":"3","key":"2025011315513021500_bib17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3324\/haematol.2021.279196","article-title":"Safety and efficacy of the BNT162b MRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia","volume":"107","author":"Benjamini","year":"2022","journal-title":"Haematologica"},{"issue":"6","key":"2025011315513021500_bib18","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1182\/bloodadvances.2021006627","article-title":"Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study","volume":"6","author":"Haydu","year":"2022","journal-title":"Blood Adv"},{"issue":"26","key":"2025011315513021500_bib19","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1200\/JCO.22.00088","article-title":"Humoral responses against SARS-CoV-2 and variants of concern after MRNA vaccines in patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"40","author":"Chang","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"2025011315513021500_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/bjh.18014","article-title":"COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity","volume":"197","author":"Shen","year":"2022","journal-title":"Br J Haematol"},{"issue":"8","key":"2025011315513021500_bib21","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1038\/s41375-020-0941-7","article-title":"COVID-19 among fit patients with CLL treated with venetoclax-based combinations","volume":"34","author":"F\u00fcrstenau","year":"2020","journal-title":"Leukemia"},{"issue":"11","key":"2025011315513021500_bib22","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.3390\/cancers15112993","article-title":"Antibody response to the SARS-CoV-2 vaccine and COVID-19 vulnerability during the omicron pandemic in patients with CLL: two-year follow-up of a multicenter study","volume":"15","author":"Mauro","year":"2023","journal-title":"Cancers"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/1\/162\/2350129\/blooda_adv-2024-013792-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/1\/162\/2350129\/blooda_adv-2024-013792-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T15:51:45Z","timestamp":1736783505000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/1\/162\/525799\/COVID-19-in-patients-with-chronic-lymphocytic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024013792","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]}}}